Circle Pharma

At Circle, they are translating some of my academic discoveries into potential therapies for patients. Drug discovery and development is challenging and I appreciate being able to work with some of the best in the industry including Nextech. Their deep expertise in oncology and continued support to Circle has enabled them to advance their macrocycle platform from discovery into clinical trials, bringing us closer to delivering innovative therapies for patients facing difficult-to-treat cancers.

William G. Kaelin, M.D.
Board Observer
Chair, Scientific Advisory Board
Circle Pharma

Circle Pharma